Point Counter Point: The Case for Cognitive
Dr. Alexander Kenigsberg explains why cognitive fusion remains a dependable strategy for focal therapy by examining accuracy, margin requirements, and anatomic planning.
Read More
Select Page
Alexander Kenigsberg, MD, is an Assistant Professor in the Department of Urology at Virginia Commonwealth University (VCU) School of Medicine and Director of Urologic Oncology at VCU Massey Comprehensive Cancer Center in Richmond, Virginia. He specializes in urologic oncology, with a clinical focus on prostate, kidney, and bladder cancers.
Dr. Kenigsberg’s clinical interests include robotic and minimally invasive cancer surgery, focal therapy for prostate cancer, high-intensity focused ultrasound (HIFU), active surveillance, and organ-preserving approaches to urologic malignancies. His research focuses on improving minimally invasive cancer treatment, focal therapy, and expanding access to clinical trials for patients with genitourinary cancers.
He earned his medical degree from New York University Grossman School of Medicine, completed his internship and urology residency at UT Southwestern Medical Center, and subsequently completed fellowship training in urologic oncology at the National Cancer Institute, National Institutes of Health.
Alexander Kenigsberg, MD | Feb 2026
Dr. Alexander Kenigsberg explains why cognitive fusion remains a dependable strategy for focal therapy by examining accuracy, margin requirements, and anatomic planning.
Read More